Forward-Looking StatementsThis press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause Catalyst's actual results in future periods to differ materially from forecasted results. A number of factors, including those factors described in Catalyst's Annual Report on Form 10-K for the fiscal year 2016 and its other filings with the U.S. Securities and Exchange Commission (SEC), could adversely affect Catalyst. Copies of Catalyst's filings with the SEC are available from the SEC, may be found on Catalyst's website, or may be obtained upon request from Catalyst. Catalyst does not undertake any obligation to update the information contained herein, which speaks only as of this date.
Investor ContactBrian KorbThe Trout Group LLC(646) firstname.lastname@example.orgCompany ContactPatrick J. McEnanyCatalyst PharmaceuticalsChief Executive Officer(305) email@example.comMedia ContactsDavid SchullRusso Partners(212) firstname.lastname@example.org